Most people begin noticing improvements within a few weeks of consistent use
Therefore, we will explore the differences between the two so that you can make the most informed decision for your needs
In REDEFINE 1 (overweight/obesity without T2D), CagriSema achieved mean weight reductions of 20.4-22.7% (vs 2.3-3.0% placebo) at 68 weeks, with 53.6% and 34.7% of patients achieving 20% and 25% weight loss, respectively
The efficacy question no press release answers: Oral small molecules historically trail injectable biologics on PASI response
In 2025, our product investments meaningfully increased engagement, and engagement translates into better results at every stage of the journey
Those foods may be fine for some people later, but week one is not the best time to test your limits